NOMANESIT

Medicinal product

(Invented) name

NOMANESIT

Active substance (s)

Sumatriptanas/Naprokseno natrio druska

Strength

85 mg/500 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N02CC, Selective serotonin (5HT1) agonists

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2026-04-20

Date of renewal

Documents

3315_NOMANESIT_PIL.docx

3315_NOMANESIT_PZ.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Sumatriptanas	85 mg
Naprokseno natrio druska	500 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
120609	106713	1106713	lizdinė plokštelė	N3		Receptinis	LT/L/26/3315/001	Netiekiama	-	-	No	-	-
120610	106714	1106714	lizdinė plokštelė	N9		Receptinis	LT/L/26/3315/002	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2026-04-20	Registruotas